Colitis ulcerosa: vizsgálatok itt: Tajvan

In Tajvan 13 Also abroad 382

13 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

2. fázisCsak meghívásos
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Changhua, Chiayi City, Kaohsiung City, Taichung, Taipei
Életkor
18 év and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
3. fázisTaking people
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Where
Taipei
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07158242 · EU 2025-522518-22-01
2. fázisTaking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Changhua, Kaohsiung City, Taichung, Taipei
Életkor
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Taichung, Tainan, Taipei, Taoyuan
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
2. fázisTaking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Changhua, Chiayi City, Kaohsiung City, Taichung, Taipei, Taoyuan City
Életkor
18 év to 75 év
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
3. fázisTaking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Taichung, Taipei
Életkor
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
2. fázisTaking people
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Where
Kaohsiung City, Taichung
Életkor
18 év to 75 év
People
2000 worldwide
Run by
AbbVie
See details and how to joinNCT07697456 · EU 2026-525959-86-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Chiayi City, Taipei
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Taoyuan City
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
3. fázisTaking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Changhua, Kaohsiung City, Zhongzheng
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
3. fázisTaking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Changhua, Kaohsiung City, Taipei
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
No phaseNot yet taking people in Tajvan
Research on the Whole Process of AI Intelligent Management System for the Diagnosis and Treatment of Inflammatory Bowel Diseases
Where
Taichung
Életkor
18 év and over
People
4500
Run by
Taichung Veterans General Hospital
See details and how to joinNCT07590271
No phaseTaking people
Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating
Where
Taichung
Életkor
18 év and over
People
200
Run by
China Medical University Hospital
See details and how to joinNCT07314151